Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense.
Phase of Trial: Phase II
Latest Information Update: 02 Jul 2015
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary)
- Indications Allergic rhinoconjunctivitis; Grass pollen hypersensitivity
- Focus Adverse reactions
- Sponsors ALK-Abello
- 29 Mar 2012 Actual patient number 236 adde as reported by ClinicalTrials.gov.
- 29 Mar 2012 Actual end date Feb 2012 added as reported by ClinicalTrials.gov.
- 29 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.